Combination photodynamic therapy and intravitreal bevacizumab used to treat circumscribed choroidal hemangioma

Journal of the Chinese Medical Association

Volumn 74, Issue 10, 2011, Pages 473-477

  Hsu, Chih Chien ^a   Yang, Chang Sue ^a,b   Peng, Chih Han ^a   Lee, Fenq Lih ^a,b   Lee, Shui Mei ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Bevacizumab; Circumscribed choroidal hemagioma; Exudative retinal detachment; Photodynamic therapy

Indexed keywords

BEVACIZUMAB; VERTEPORFIN;

ADULT; ARTICLE; B SCAN; BLURRED VISION; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CASE REPORT; CHOROID TUMOR; CIRCUMSCRIBED CHOROIDAL HEMANGIOMA; DISEASE COURSE; EYE EXAMINATION; FLUORESCENCE ANGIOGRAPHY; HEMANGIOMA; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; RETINA DETACHMENT; SCOTOMA; VISUAL ACUITY;

ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHOROID NEOPLASMS; COMBINED MODALITY THERAPY; HEMANGIOMA; HUMANS; INTRAVITREAL INJECTIONS; MALE; PHOTOCHEMOTHERAPY; TREATMENT OUTCOME;

EID: 80955164812     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2011.08.020     Document Type: Article

References (17)

1. Gass J.D.M. Differential diagnosis of intraocular tumors: a stereoscopic presentation 1974, CV Mosby, St. Louis, p.113-118.
2. Scott I.U., Gorscak J., Gass J.D., Feuer W.J., Murray T.G. Anatomic and visual acuity outcomes following thermal laser photocoagulation or photodynamic therapy for symptomatic circumscribed choroidal hemangioma with associated serous retinal detachment. Ophthalmic Surg Laser Imag 2004, 35:281-291.
3. Shields J.A., Shields C.L., Materin M.A., Marr B.P., Demirci H., Mashayekhi A. Changing concepts in management of circumscribed choroidal hemangioma: the 2003 J. Howard stokes lecture, part 1. Ophthalmic Surg Laser Imag 2004, 35:383-394.
4. Shields C.L., Honavar S.G., Shields J.A., Cater J., Demirci H. Circumscribed choroidal hemangioma: clinical manifestations and factors predictive of visual outcome in 200 consecutive cases. Ophthalmology 2001, 108:2237-2248.
5. Schilling H., Sauerwein W., Lommatzsh A., Friedrichs W., Brylak S., Bornfeld N., et al. Long-term results after low dose ocular irradiation for choroidal hemangiomas. Br J Ophthalmol 1997, 81:267-273.
6. Ritland J.S., Eide N., Tausjo J. External beam irradiation therapy for chorodial hemangiomas. Visual and anatomical results after a dose of 20 to 25 Gy. Acta Ophthalmol Scand 2001, 79:184-186.
7. Frau E., Rumen F., Noel G., Delacroix S., Habrand J.L., Offret H. Low-dose proton beam therapy for circumscribed choroidal hemangiomas. Arch Ophthalmol 2004, 122:1471-1475.
8. Barbazetto I., Schmidt-Erfurth U. Photodynamic therapy of choroidal hemangioma: two case reports. Graefes Arch Clin Exp Ophthalmol 2000, 238:214-221.
9. Jurklies B., Anastassiou G., Ortmans S., Schüler A., Schilling H., Schmidt-Erfurth U., et al. Photodynamic therapy using verteporfin in circumscribed choroidal haemangioma. Br J Ophthalmol 2003, 87:84-89.
10. Gupta M., Singh A.D., Rundle P.A., Rennie I.G. Efficacy of photodynamic therapy in circumscribed choroidal hemangioma. Eye 2004, 18:139-142.
11. Khuu T., Hoffman D.J. Circumscribed choroidal hemangioma: a case report and review of the literature. Optometry 2006, 77:384-391.
12. Boixadera A., García-Arumí J., Martínez-Castillo V., Encinas J.L., Elizalde J., Blanco-Mateos G., et al. Prospective clinical trial evaluating the efficacy of photodynamic therapy for symptomatic circumscribed choroidal hemangioma. Ophthalmology 2009, 116:100-105.
13. Michels S., Michels R., Simader C., Schmidt-Erfurth U. Verteporfin therapy for choroidal hemangioma: a long-term follow-up. Retina 2005, 25:697-703.
14. Noma H., Funatsu H., Yamasaki M., Tsukamoto H., Mimura T., Sone T., et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 2005, 140:256-261.
15. Wang W., Dentler W.L., Borchardt R.T. VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am J Physiol Heart Circ Physiol 2001, 280:H434-H440.
16. Hurwitz H., Fehrenbacher L., Novotny W., Cartwright T., Hainsworth J., Heim W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004, 350:2335-2342.
17. Sagong M., Lee J., Chang W. Application of intravitreal bevacizumab for circumscribed choroidal hemangioma. Korean J Ophthalmol 2009, 23:127-131.